Holen Sie sich die Stockscreener-App
19.50
0.36%
-0.07
Handel nachbörslich:
19.50
Schlusskurs vom Vortag:
$19.57
Offen:
$19.57
24-Stunden-Volumen:
632.10K
Relative Volume:
0.74
Marktkapitalisierung:
$1.22B
Einnahmen:
$330.50M
Nettoeinkommen (Verlust:
$145.42M
KGV:
11.82
EPS:
1.65
Netto-Cashflow:
$157.96M
1W Leistung:
-0.41%
1M Leistung:
-7.14%
6M Leistung:
+4.00%
1J Leistung:
+13.44%
1-Tages-Spanne:
$19.41
$19.69
1-Wochen-Bereich:
$19.35
$20.58
52-Wochen-Spanne:
$16.67
$22.00
Innoviva Inc Stock (INVA) Company Profile
Firmenname
Innoviva Inc
Sektor
Branche
Telefon
(650) 238-9600
Adresse
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Vergleichen Sie INVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
19.50 | 1.23B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Eingeleitet | Goldman | Neutral |
| 2017-11-20 | Eingeleitet | Deutsche Bank | Hold |
Alle ansehen
Innoviva Inc Aktie (INVA) Neueste Nachrichten
What drives Innoviva Inc. stock priceStrong return on assets - jammulinksnews.com
Innoviva Inc. Stock Analysis and ForecastFastest return on investment - PrintWeekIndia
Teacher Retirement System of Texas Reduces Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Financial Analysis: Innoviva (NASDAQ:INVA) versus Bayer Aktiengesellschaft (OTCMKTS:BAYRY) - Defense World
Is Innoviva Inc. a good long term investmentSuperior stock growth - Autocar Professional
What analysts say about Innoviva Inc. stockFree Market Dynamics Reports - jammulinksnews.com
What risks could impact Innoviva Inc. stock performanceSafe Entry High Exit Alerts - Newser
Innoviva (NASDAQ:INVA) & Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Financial Review - Defense World
Equities Analysts Set Expectations for Innoviva Q2 Earnings - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Acquired by Principal Financial Group Inc. - Defense World
(INVA) Proactive Strategies - news.stocktradersdaily.com
Innoviva (NASDAQ:INVA) Coverage Initiated at HC Wainwright - Defense World
What makes Innoviva Inc. stock price move sharplyTop Gaining Low Risk Assets - Newser
How Innoviva Inc. stock performs during market volatilityFree Exclusive Group - Newser
Why Innoviva Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser
H.C. Wainwright Initiates Innoviva(INVA.US) With Buy Rating, Announces Target Price $40 - 富途牛牛
HC Wainwright Initiates Innoviva at Buy With $40 Price Target - MarketScreener
This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Cantor Fitzgerald Predicts Innoviva FY2026 Earnings - Defense World
Cantor Fitzgerald Begins Coverage on Innoviva (NASDAQ:INVA) - Defense World
New York State Teachers Retirement System Sells 3,448 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Head to Head Analysis: Merck & Co., Inc. (NYSE:MRK) versus Innoviva (NASDAQ:INVA) - Defense World
(INVA) Long Term Investment Analysis - news.stocktradersdaily.com
Illinois Municipal Retirement Fund Sells 1,260 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Ratio Stays Despite Growth Signs Nasdaq Composite - Kalkine Media
Innoviva, Inc.'s (NASDAQ:INVA) Low P/S No Reason For Excitement - simplywall.st
SG Americas Securities LLC Makes New $737,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Rhumbline Advisers Sells 9,188 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
FDA Grants Priority Review for Innoviva's (INVA) Zoliflodacin | - GuruFocus
FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025 - Kalkine Media
FDA reviews new gonorrhea antibiotic from Innoviva By Investing.com - Investing.com South Africa
FDA Reviews Innoviva's (INVA) Zoliflodacin for Gonorrhea Treatment - GuruFocus
Innoviva Says FDA Accepts New Drug Application for Zoliflodacin - MarketScreener
Innoviva Specialty's gonorrhea antibiotic to undergo FDA review (INVA) - Seeking Alpha
FDA reviews new gonorrhea antibiotic from Innoviva - Investing.com Australia
Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults - BioSpace
Innoviva (INVA) Awaits FDA Decision on New Gonorrhea Antibiotic | INVA Stock News - GuruFocus
Transcript : Innoviva, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - MarketScreener
Innoviva: A Riddle Wrapped In A Mystery Inside An Enigma (NASDAQ:INVA) - Seeking Alpha
Finanzdaten der Innoviva Inc-Aktie (INVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):